Stephen Baxter
Stock Analyst at Wells Fargo
(3.30)
# 1,052
Out of 5,124 analysts
231
Total ratings
49.67%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Upgrades: Overweight | $29 → $31 | $28.41 | +9.12% | 3 | Nov 18, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $14 → $11 | $16.57 | -33.61% | 13 | Nov 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $103 → $102 | $80.42 | +26.83% | 16 | Nov 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $249 → $259 | $222.87 | +16.21% | 16 | Nov 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $238 → $252 | $207.01 | +21.73% | 16 | Nov 13, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $412 → $431 | $477.83 | -9.80% | 17 | Nov 13, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $231 → $165 | $182.80 | -9.74% | 21 | Nov 12, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $41 → $35 | $44.68 | -21.67% | 24 | Nov 12, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $33 → $39 | $39.26 | -0.66% | 7 | Nov 12, 2025 | |
| COR Cencora | Maintains: Overweight | $354 → $405 | $340.92 | +18.80% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $824.92 | +10.80% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.69 | +44.40% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $283.97 | +5.64% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $185 → $221 | $205.45 | +7.57% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $412 → $403 | $363.51 | +10.86% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $342.02 | +16.95% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $344 → $347 | $275.80 | +25.82% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.26 | -7.98% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.28 | +106.04% | 3 | Apr 29, 2024 |
The Pennant Group
Nov 18, 2025
Upgrades: Overweight
Price Target: $29 → $31
Current: $28.41
Upside: +9.12%
Oscar Health
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $16.57
Upside: -33.61%
CVS Health
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $80.42
Upside: +26.83%
Universal Health Services
Nov 13, 2025
Maintains: Overweight
Price Target: $249 → $259
Current: $222.87
Upside: +16.21%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $238 → $252
Current: $207.01
Upside: +21.73%
HCA Healthcare
Nov 13, 2025
Maintains: Equal-Weight
Price Target: $412 → $431
Current: $477.83
Upside: -9.80%
Molina Healthcare
Nov 12, 2025
Maintains: Overweight
Price Target: $231 → $165
Current: $182.80
Upside: -9.74%
Centene
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $41 → $35
Current: $44.68
Upside: -21.67%
BrightSpring Health Services
Nov 12, 2025
Maintains: Overweight
Price Target: $33 → $39
Current: $39.26
Upside: -0.66%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $340.92
Upside: +18.80%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $824.92
Upside: +10.80%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.69
Upside: +44.40%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $283.97
Upside: +5.64%
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $205.45
Upside: +7.57%
Oct 22, 2025
Maintains: Overweight
Price Target: $412 → $403
Current: $363.51
Upside: +10.86%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $342.02
Upside: +16.95%
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $275.80
Upside: +25.82%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.26
Upside: -7.98%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.28
Upside: +106.04%